Viewing nowCombinationHyuniz Valsartan Tablet 5/160mg (Amlodipine, Valsartan)
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Huons Meditech Co., Ltd.

MFDS item code 201503876 · Approved 2015.06.15 · Insurance code 670401000
Treatment of essential hypertension not controlled with monotherapy
This medication is used to stabilize blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Safety and efficacy have not been established in pediatric patients under 18 years of age; use of this medicine is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients of this medication or similar drugs, women who are pregnant or breastfeeding, and patients with severe renal or hepatic impairment should not take this medication. Patients with low sodium or fluid levels may experience hypotension, so their condition should be carefully checked before taking the medication, and blood pressure and condition should be closely monitored while on treatment. Patients with elevated potassium levels should frequently monitor potassium levels when taking this medication alongside other drugs that can increase potassium. Patients with renal vascular issues or those who have undergone kidney transplants should take this medication with special caution as it may affect kidney function. If angioedema (swelling due to airway obstruction or swelling of the face, lips, or tongue) occurs, the medication should be discontinued immediately and should not be taken again. Patients with heart failure or those post-myocardial infarction should frequently check kidney function and blood pressure when taking this medication, and attention should be paid to the worsening of heart failure. Patients with acute myocardial infarction or aortic stenosis should also take this medication with caution. This medication should not be taken in conjunction with other angiotensin-related drugs to avoid increased risk of hypotension, renal function deterioration, or hyperkalemia. Caution should be exercised when driving or operating machinery, as dizziness or fatigue may occur. In case of overdose, severe hypotension or heart rhythm abnormalities may occur, and immediate medical attention should be sought if overdose is suspected. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. It is not recommended for children under 18 years of age as safety and efficacy have not been adequately established. Elderly patients may be administered similar doses as adults, but monitoring their condition is crucial. During the course of this medication, regular checks on blood pressure, kidney function, and blood potassium levels should be conducted to ensure there are no abnormalities.
pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, taste abnormalities, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, irritability, sensory reduction, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container, away from air and moisture. It is also advisable to keep it at room temperature between 1 degree and 30 degrees Celsius.
Dark yellow oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Huons Meditech Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.